phenoxybenzamine has been researched along with Obesity in 2 studies
Phenoxybenzamine: An alpha-adrenergic antagonist with long duration of action. It has been used to treat hypertension and as a peripheral vasodilator.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Levin, BE | 1 |
| Comai, K | 2 |
| Sullivan, AC | 2 |
2 other studies available for phenoxybenzamine and Obesity
| Article | Year |
|---|---|
Metabolic and sympatho-adrenal abnormalities in the obese Zucker rat: effect of chronic phenoxybenzamine treatment.
Topics: Animals; Blood Glucose; Body Temperature; Body Weight; Dopamine; Eating; Epinephrine; Glycerol; Insu | 1981 |
Effect of phenoxybenzamine on development of adipose tissue in lean and obese Zucker rats.
Topics: Adipose Tissue; Aging; Animals; Body Weight; Energy Intake; Feeding Behavior; Growth; Male; Obesity; | 1982 |